SEARCH

SEARCH BY CITATION

References

  • Alessandrì MG, Celati L, Battini R, Baldinotti F, Item C, Leuzzi V, Cioni G. (2004) HPLC assay for guanidinoacetate methyltransferase. Anal Biochem331:189191.
  • Almeida LS, Verhoeven NM, Roos B, Valongo C, Cardoso ML, Vilarinho L, Salomons GS, Jakobs C. (2004) Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab82:214219.
  • Almeida LS, Vilarinho L, Darmin PS, Rosenberg EH, Martinez-Muñoz C, Jakobs C, Salomons GS. (2007) A prevalent pathogenic GAMT mutation (c.59G>C) in Portugal. Mol Genet Metab91:16.
  • Anselm IA, Alkuraya FS, Salomons GS, Jakobs C, Fulton AB, Mazumdar M, Rivkin M, Frye R, Poussaint TY, Marsden D. (2006) X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype. J Inherit Metab Dis29:214219.
  • Ardon O, Amat di San Filippo C, Salomons GS, Longo N. (2010) Creatine transporter deficiency in two half-brothers. Am J Med Genet A152A:19791983.
  • Arias A, Corbella M, Fons C, Sempere A, García-Villoria J, Ormazabal A, Poo P, Pineda M, Vilaseca MA, Campistol J, Briones P, Pàmpols T, Salomons GS, Ribes A, Artuch R. (2007) Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening. Clin Biochem40:13281331.
  • Battini R, Leuzzi V, Carducci C, Tosetti M, Bianchi MC, Item CB, Stöckler-Ipsiroglu S, Cioni G. (2002) Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree. Mol Genet Metab77:326331.
  • Battini R, Alessandrì MG, Leuzzi V, Moro F, Tosetti M, Bianchi MC, Cioni G. (2006) Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: early treatment can prevent phenotypic expression of the disease. J Pediatr148:828830.
  • Battini R, Chilosi A, Mei D, Casarano M, Alessandrì MG, Leuzzi V, Ferretti G, Tosetti M, Bianchi MC, Cioni G. (2007) Mental retardation and verbal dyspraxia in a new patient with de novo creatine transporter (SLC6A8) mutation. Am J Med Genet A143A:17711774.
  • Battini R, Chilosi AM, Casarano M, Moro F, Comparini A, Alessandrì MG, Leuzzi V, Tosetti M, Cioni G. (2011) Language disorder with mild intellectual disability in a child affected by a novel mutation of SLC6A8 gene. Mol Genet Metab102:153156.
  • Bianchi MC, Tosetti M, Fornai F, Alessandri’ MG, Cipriani P, De Vito G, Canapicchi R. (2000) Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann Neurol47:511513.
  • Bianchi MC, Tosetti M, Battini R, Leuzzi V, Alessandri’ MG, Carducci C, Antonozzi I, Cioni G. (2007) Treatment monitoring of brain creatine deficiency syndromes: a 1H- and 31P-MR spectroscopy study. AJNR Am J Neuroradiol28:548554.
  • Braissant O. (2012) Creatine and guanidinoacetate transport at blood–brain and blood–cerebrospinal fluid barriers. J Inherit Metab Dis35:655664.
  • Braissant O, Béard E, Torrent C, Henry H. (2010) Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes. Neurobiol Dis37:423433.
  • Braissant O, Henry H, Béard E, Uldry J. (2011) Creatine deficiency syndromes and the importance of creatine synthesis in the brain. Amino Acids40:13151324.
  • Caldeira Araujo H, Smit W, Verhoeven NM, Salomons GS, Silva S, Vasconcelos R, Tomás H, Tavares de Almeida I, Jakobs C, Duran M. (2005) Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation. Am J Med Genet A133A:122127.
  • Carducci C, Birarelli M, Leuzzi V, Carducci C, Battini R, Cioni G, Antonozzi I. (2002) Guanidinoacetate and creatine plus creatinine assessment in physiologic fluids: an effective diagnostic tool for the biochemical diagnosis of arginine:glycine amidinotransferase and guanidinoacetate methyltransferase deficiencies. Clin Chem48:17721778.
  • Carducci C, Santagata S, Leuzzi V, Carducci C, Artiola C, Giovanniello T, Battini R, Antonozzi I. (2006) Quantitative determination of guanidinoacetate and creatine in dried blood spot by flow injection analysis-electrospray tandem mass spectrometry. Clin Chim Acta364:180187.
  • Carducci C, Carducci C, Santagata S, Adriano E, Artiola C, Thellung S, Gatta E, Robello M, Florio T, Antonozzi I, Leuzzi V, Balestrino M. (2012) In vitro study of uptake and synthesis of creatine and its precursors by cerebellar granule cells and astrocytes suggests some hypotheses on the physiopathology of the inherited disorders of creatine metabolism. BMC Neurosci13:41.
  • Cecil KM, Salomons GS, Ball WS Jr, Wong B, Chuck G, Verhoeven NM, Jakobs C, DeGrauw TJ. (2001) Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?Ann Neurol49:401404.
  • Cecil KM, DeGrauw TJ, Salomons GS, Jakobs C, Egelhoff JC, Clark JF. (2003) Magnetic resonance spectroscopy in a 9-day-old heterozygous female child with creatine transporter deficiency. J Comput Assist Tomogr27:4447.
  • Chilosi A, Leuzzi V, Battini R, Tosetti M, Ferretti G, Comparini A, Casarano M, Moretti E, Alessandri MG, Bianchi MC, Cioni G. (2008) Treatment with L-arginine improves neuropsychological disorders in a child with creatine transporter defect. Neurocase14:151161.
  • Clark AJ, Rosenberg EH, Almeida LS, Wood TC, Jakobs C, Stevenson RE, Schwartz CE, Salomons GS. (2006) X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology. Hum Genet 119:604610.
  • De Deyn PP, Macdonald RL. (1990) Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. Ann Neurol28:627633.
  • DeGrauw TJ, Salomons GS, Cecil KM, Chuck G, Newmeyer A, Schapiro MB, Jakobs C. (2002) Congenital creatine transporter deficiency. Neuropediatrics33:232238.
  • DeGrauw TJ, Cecil KM, Byars AW, Salomons GS, Ball WS, Jakobs C. (2003) The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem244:4548.
  • Dhar SU, Scaglia F, Li FY, Smith L, Barshop BA, Eng CM, Haas RH, Hunter JV, Lotze T, Maranda B, Willis M, Abdenur JE, Chen E, O’Brien W, Wong LJ. (2009) Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Mol Genet Metab96:3843.
  • Edvardson S, Korman SH, Livne A, Shaag A, Saada A, Nalbandian R, Allouche-Arnon H, Gomori JM, Katz-Brull R. (2010) L-arginine:glycine amidinotransferase (AGAT) deficiency: clinical presentation and response to treatment in two patients with a novel mutation. Mol Genet Metab101:228232.
  • Ensenauer R, Thiel T, Schwab KO, Tacke U, Stöckler-Ipsiroglu S, Schulze A, Hennig J, Lehnert W. (2004) Guanidinoacetate methyltransferase deficiency: differences of creatine upatientake in human brain and muscle. Mol Genet Metab82:208213.
  • Fons C, Sempere A, Arias A, López-Sala A, Póo P, Pineda M, Mas A, Vilaseca MA, Salomons GS, Ribes A, Artuch R, Campistol J. (2008) Arginine supplementation in four patients with X-linked creatine transporter defect. J Inherit Metab Dis31:724728.
  • Hinnell C, Samuel M, Alkufri F, Ashkan K, Rahman Y, Turner C, Dalton RN, Nashef L. (2011) Creatine deficiency syndromes: diagnostic pearls and pitfalls. J Neurol Sci38:765767.
  • Ilas J, Muhl A, Stöckler-Ipsiroglu S. (2000) Guanidinoacetate methyltransferase (GAMT) deficiency: non-invasive enzymatic diagnosis of anew recognised inborn error of metabolism. Clin Chim Acta290:179188.
  • Item CB, Stöckler-Ipsiroglu S, Stromberger C, Mühl A, Alessandrì MG, Bianchi MC, Tosetti M, Fornai F, Cioni G. (2001) Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet69:11271133.
  • Kan HE, Buse-Pot TE, Peco R, Isbrandt D, Heerschap A, de Haan A. (2005) Lower force and impaired performance during high-intensity electrical stimulation in skeletal muscle of GAMT-deficient knockout mice. Am J Physiol Cell Physiol289:C113C119.
  • Kleefstra T, Rosenberg EH, Salomons GS, Stroink H, van Bokhoven H, Hamel BC, de Vries BB. (2005) Progressive intestinal, neurological and psychiatric problems in two adult males with cerebral creatine deficiency caused by an SLC6A8 mutation. Clin Genet68:379381.
  • Kolling J, Wyse AT. (2010) Creatine prevents the inhibition of energy metabolism and lipid peroxidation in rats subjected to GAA administration. Metab Brain Dis25:331338.
  • Kurosawa Y, Degrauw TJ, Lindquist DM, Blanco VM, Pyne-Geithman GJ, Daikoku T, Chambers JB, Benoit SC, Clark JF. (2012) Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency. J Clin Invest122:28372846.
  • Leuzzi V, Bianchi MC, Tosetti M, Carducci C, Cerquiglini CA, Cioni G, Antonozzi I. (2000) Brain creatine depletion: guanidinoacetate methyltransferase deficiency (improving with creatine supplementation). Neurology55:14071409.
  • Leuzzi V, Carducci C, Carducci C, Matricardi M, Bianchi MC, Di Sabato ML, Artiola C, Antonozzi I. (2006) A mutation on exon 6 of guanidinoacetate methyltransferase (GAMT) gene supports a different function for isoform a and b of GAMT enzyme. Mol Genet Metab87:8890.
  • Leuzzi V, Alessandrì MG, Casarano M, Battini R, Cioni G. (2008) Arginine and glycine stimulate creatine synthesis in creatine transporter 1-deficient lymphoblasts. Anal Biochem375:153155.
  • Mak CS, Waldvogel HJ, Dodd JR, Gilbert RT, Lowe MT, Birch NP, Faull RL, Christie DL. (2009) Immunohistochemical localisation of the creatine transporter in the rat brain. Neuroscience163:571585.
  • Mancardi MM, Caruso U, Schiaffino MC, Baglietto MG, Rossi A, Battaglia FM, Salomons GS, Jakobs C, Zara F, Veneselli E, Gaggero R. (2007) Severe epilepsy in X-linked creatine transporter defect (CRTR-D). Epilepsia48:12111213.
  • Mancini GM, Catsman-Berrevoets CE, de Coo IF, Aarsen FK, Kamphoven JH, Huijmans JG, Duran M, van der Knaap MS, Jakobs C, Salomons GS. (2005) Two novel mutations in SLC6A8 cause creatine transporter defect and distinctive X-linked mental retardation in two unrelated Dutch families. Am J Med Genet A132A:288295.
  • Mercimek-Mahmutoglu S, Stoeckler-Ipsiroglu S, Adami A, Appleton R, Caldeira Araújo HC, Duran M, Ensenauer R, Fernandez-Alvarez E, Garcia P, Grolik C, Item CB, Leuzzi V, Marquardt I, Mühl A, Saelke-Kellermann RA, Salomons GS, Schulze A, Surtees R, van der Knaap MS, Vasconcelos R, Verhoeven NM, Vilarinho L, Wilichowski E, Jakobs C. (2006) GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology67:480484.
  • Mercimek-Mahmutoglu S, Connolly MB, Poskitt KJ, Horvath GA, Lowry N, Salomons GS, Casey B, Sinclair G, Davis C, Jakobs C, Stöckler-Ipsiroglu S. (2010) Treatment of intractable epilepsy in a female with SLC6A8 deficiency. Mol Genet Metab101:409412.
  • Mercimek-Mahmutoglu S, Dunbar M, Friesen A, Garret S, Hartnett C, Huh L, Sinclair G, Stöckler S, Wellington S, Pouwels PJ, Salomons GS, Jakobs C. (2012) Evaluation of two year treatment outcome and limited impact of arginine restriction in a patient with GAMT deficiency. Mol Genet Metab105:155158.
  • Ndika JD, Johnston K, Barkovich JA, Wirt MD, O’Neill P, Betsalel OT, Jakobs C, Salomons GS. (2012) Developmental progress and creatine restoration upon long-term creatine supplementation of a patient with arginine:glycine amidinotransferase deficiency. Mol Genet Metab106:4854.
  • Neu A, Neuhoff H, Trube G, Fehr S, Ullrich K, Roeper J, Isbrandt D. (2002) Activation of GABA(A) receptors by guanidinoacetate: a novel pathophysiological mechanism. Neurobiol Dis11:298307.
  • O’Rourke DJ, Ryan S, Salomons G, Jakobs C, Monavari A, King MD. (2009) Guanidinoacetate methyltransferase (GAMT) deficiency: late onset of movement disorder and preserved expressive language. Dev Med Child Neurol51:404407.
  • Póo-Argüelles P, Arias A, Vilaseca MA, Ribes A, Artuch R, Sans-Fito A, Moreno A, Jakobs C, Salomons G. (2006) X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism. J Inherit Metab Dis29:220223.
  • Pyne-Geithman GJ, deGrauw TJ, Cecil KM, Chuck G, Lyons MA, Ishida Y, Clark JF. (2004) Presence of normal creatine in the muscle of a patient with a mutation in the creatine transporter: a case study. Mol Cell Biochem262:3539.
  • Rosenberg EH, Almeida LS, Kleefstra T, deGrauw RS, Yntema HG, Bahi N, Moraine C, Ropers HH, Fryns JP, deGrauw TJ, Jakobs C, Salomons GS. (2004) High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet75:97105.
  • Salomons GS, van Dooren SJ, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, Jakobs C. (2001) X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet68:14971500.
  • Schiaffino MC, Bellini C, Costabello L, Caruso U, Jakobs C, Salomons GS, Bonioli E. (2005) X-linked creatine transporter deficiency: clinical description of a patient with a novel SLC6A8 gene mutation. Neurogenetics6:165168.
  • Schmidt A, Marescau B, Boehm EA, Renema WK, Peco R, Das A, Steinfeld R, Chan S, Wallis J, Davidoff M, Ullrich K, Waldschütz R, Heerschap A, De Deyn PP, Neubauer S, Isbrandt D. (2004) Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum Mol Genet13:905921.
  • Schulze A, Hess T, Wevers R, Mayatepek E, Bachert P, Marescau B, Knopp MV, De Deyn PP, Bremer HJ, Rating D. (1997) Creatine deficiency syndrome caused by guanidinoacetico methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. J Pediatr131:626631.
  • Schulze A, Ebinger F, Rating D, Mayatepek E. (2001) Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab74:413419.
  • Schulze A, Bachert P, Schlemmer H, Harting I, Polster T, Salomons GS, Verhoeven NM, Jakobs C, Fowler B, Hoffmann GF, Mayatepek E. (2003) Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol53:248251.
  • Schulze A, Hoffmann GF, Bachert P, Kirsch S, Salomons GS, Verhoeven NM, Mayatepek E. (2006) Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology67:719721.
  • Sijens PE, Verbruggen KT, Oudkerk M, van Spronsen FJ, Soorani-Lunsing RJ. (2005) 1H MR spectroscopy of the brain in Cr transporter defect. Mol Genet Metab86:421422.
  • Skelton MR, Schaefer TL, Graham DL, Degrauw TJ, Clark JF, Williams MT, Vorhees CV. (2011) Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency. PLoS ONE6:e16187.
  • Stöckler S, Isbrandt D, Hanefeld F, Schmidt B, von Figura K. (1996) Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet91:4922.
  • Stöckler S, Schutz PW, Salomons GS. (2007) Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem46:149166.
  • Tachikawa M, Fukaya M, Terasaki T, Ohtsuki S, Watanabe M. (2004) Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron–glial relationship for brain energy homeostasis. Eur J Neurosci20:144160.
  • Tachikawa M, Fujinawa J, Takahashi M, Kasai Y, Fukaya M, Sakai K, Yamazaki M, Tomi M, Watanabe M, Sakimura K, Terasaki T, Hosoya K. (2008) Expression and possible role of creatine transporter in the brain and at the blood–cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant. J Neurochem107:768778.
  • Torremans A, Marescau B, Possemiers I, Van Dam D, D’Hooge R, Isbrandt D, De Deyn PP. (2005) Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency. J Neurol Sci231:4955.
  • Valayannopoulos V, Boddaert N, Chabli A, Barbier V, Desguerre I, Philippe A, Afenjar A, Mazzuca M, Cheillan D, Munnich A, de Keyzer Y, Jakobs C, Salomons GS, de Lonlay P. (2012) Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J Inherit Metab Dis35:151157.
  • Van de Kamp JM, Mancini GM, Pouwels PJ, Betsalel OT, van Dooren SJ, de Koning I, Steenweg ME, Jakobs C, van der Knaap MS, Salomons GS. (2011) Clinical features and X-inactivation in females heterozygous for creatine transporter defect. Clin Genet79:264272.
  • Van de Kamp JM, Pouwels PJ, Aarsen FK, ten Hoopen LW, Knol DL, de Klerk JB, de Coo IF, Huijmans JG, Jakobs C, van der Knaap MS, Salomons GS, Mancini GM. (2012) Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect. J Inherit Metab Dis35:141149.
  • Van der Knaap MS, Verhoeven NM, Maaswinkel-Mooij P, Pouwels PJ, Onkenhout W, Peeters EA, Stöckler-Ipsiroglu S, Jakobs C. (2003) Mental retardation and behavioural problems as presenting signs of a creatine synthesis defect. Ann Neurol47:540543.
  • Vodopiutz J, Item CB, Häusler M, Korall H, Bodamer OA. (2007) J Severe speech delay as the presenting symptom of guanidinoacetate methyltransferase deficiency. J Child Neurol22:773774.
  • Wyss M, Kaddurah-Daouk R. (2000) Creatine and creatine metabolism. Physiol Rev80:11071213.
  • Zimmerman RA. (2011) Neuroimaging of inherited metabolic disorders producing seizures. Brain Dev33:734744.
  • Zugno AI, Scherer EB, Schuck PF, Oliveira DL, Wofchuk S, Wannmacher CM, Wajner M, Wyse AT. (2006) Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum. Metab Brain Dis21:4150.
  • Zugno AI, Scherer EB, Mattos C, Ribeiro CA, Wannmacher CM, Wajner M, Wyse AT. (2007) Evidence that the inhibitory effects of guanidinoacetate on the activities of the respiratory chain, Na+,K+-ATPase and creatine kinase can be differentially prevented by taurine and vitamins E and C administration in rat striatum in vivo. Biochim Biophys Acta1772:563569.